Press Release: GHIF Leads $7.5 Million Investment in Korean Vaccine Manufacturer

Global Health Investment Fund Leads 7.5 Million USD Investment into EuBiologics to Catalyze Availability of Low-Cost Oral Cholera Vaccine for the World’s Poor  Korean biopharmaceutical company commits to manufacture a new and improved presentation of the vaccine at a target price of $1.00 per dose for public sector buyers  August 27, 2014 (SEOUL): Global Health [...]

By |2018-02-23T14:44:40+00:00August 27th, 2014|Uncategorized|0 Comments
Read More

Press Release: GHIF Purchases $8 Million Convertible Bond to Finance New TB Diagnostic

  Global Health Investment Fund Announcement of Collaborative Funding Agreement with Epistem PLC Investment will support the roll-out of Epistem's Genedrive® molecular diagnostic platform as the company's tuberculosis assay enters pivotal field trials in key developing world locations July 22, 2014 (LONDON): The Global Health Investment Fund I, LLC (GHIF), is pleased to announce today that it [...]

By |2018-02-23T14:44:40+00:00July 22nd, 2014|Uncategorized|0 Comments
Read More

Important Information

This website does not constitute an offer or solicitation with respect to interests in GHIF or any other securities. Offers and sales of interests in GHIF have not been and will not be registered under the U.S. Securities Act and such interests may be sold only to accredited investors. Neither the U.S. Securities and Exchange Commission nor any other regulatory authority has passed upon the merits of an investment in GHIF or the accuracy or adequacy of this website. Interests in GHIF are not subject to the protections of the U.S. Investment Company Act of 1940.
Copyright 2016 Global Health Investment Advisors, LLC | All Rights Reserved | Powered by WordPress | Theme Fusion
Go to Top